天美传媒

Christine Reilley is the Managing Director of Publishing for the American Society of Mechanical Engineers (ASME), based in New York City. Most recently, she was Managing Director of Strategy and Innovation. Previously, she led the Healthcare Technology Team, which focuses on creating and growing the Society’s portfolio of programs, products, and services in this area. Christine also has served as a program manager in the ASME Emerging Technologies unit, developing content and conferences in areas focusing on bioengineering, nanotechnology, thermofluids, and materials. Previously, she spent more than 10 years in ASME Codes and Standards Publishing as an editor, overseeing the production of codes from manuscript to final bound and digital product.

Balaji Narasimhan directs the Nanovaccine Institute based at Iowa State University. The institute is looking for new and better ways to prevent disease, including influenza and cancers. Nanovaccines, unlike current vaccines, are based on tiny particles that can send pathogen-like signals to immune cells. They can prevent disease. They can boost the immune system鈥檚 own response to disease. Production is quick. Storage is easy. And the technology is sustainable. 鈥淭his is truly one of the dream teams working on vaccine research anywhere in the world,鈥� Narasimhan said.

Dr. Sujatha Kannan is an associate professor of anesthesiology and critical care medicine and pediatrics at the Johns Hopkins University School of Medicine. She specializes in pediatric critical care. In addition to her role at Johns Hopkins, Dr. Kannan is also a research scientist at the Hugo Moser Researcher Institute at Kennedy Krieger Institute.

Dr. Kannan completed her medical training at the Jawaharlal Institute of Post Graduate Medical Education and Research in Pondicherry, India. She conducted residencies in pediatrics at the University Illinois at Chicago and the Children鈥檚 Hospital of Michigan. Additionally, she completed a fellowship in pediatric critical care medicine at the Children鈥檚 Hospital of Michigan. Dr. Kannan joined the Johns Hopkins faculty in 2011.

Her research focuses on imaging and targeted therapy for perinatal brain injury using nanotechnology, with a special emphasis on cerebral palsy and autism.

Dr. Kannan is a member of the Society for Neuroscience, the International Society for Cerebral Blood Flow and Metabolism, the Society of Critical Care Medicine, the Society for Pediatric Research and the American Academy of Pediatrics. She has published extensively and has won several awards for her research. She is board certified in pediatrics and pediatric critical care.

Matthew Bernards joins the Department of Chemical and Materials Engineering as an assistant professor. Prior to joining the University of Idaho, Bernards served as an assistant professor of Chemical Engineering at the University of Missouri, where he also held appointments in the Nuclear Engineering Program and Bioengineering Department. He graduated with his doctorate in chemical engineering and nanotechnology from the University of Washington in 2008. Bernards’ research group is focused on multiple aspects of materials science and engineering. One aspect of his research group is focused on understanding the interactions that occur between biological entities and material interfaces and using this knowledge to design biomaterials that facilitate healing at the molecular level. Another aspect of his research group is focused on developing micro- and nano-scale power generation systems based on nuclear energy.